Track topics on Twitter Track topics that are important to you
We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialysis patients.
In addition, WelCholTM brand colesevelam hydrochloride was granted marketing approval by the FDA in May 2000, for the treatment of hypercholesterolemia, a condition characterized by undesirably high blood cholesterol levels.
153 Second Avenue
United States of America
Phone: 781 290 5888
Fax: 781 290 5890
SAN FRANCISCO, CA--(Marketwired - June 02, 2016) - Cancer patients often receive multiple rounds of chemotherapy, with new drugs incorporated into treatment programs as tumors develop resistance. Onc...
CATERPILLAR INC. FILES FORM 8-K PEORIA, Illinois, April 22, 2016 - Caterpillar Inc. (NYSE: CAT/Euronext: CATR) informs its stockholders that today Caterpillar Inc. furnished a Form 8-K to the SEC ...
Caterpillar Again Named to Dow Jones Sustainability Indices Caterpillar leads global peers in Innovation Management and other key indicators PEORIA, Ill., Sept. 12, 2016 -- Caterpillar Inc. (NYSE:...
MENLO PARK, CA -- (Marketwired) -- 07/26/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on Augus...
Caterpillar to Participate in the Wells Fargo Securities Industrial and Construction Conference on May 11; Webcast Available PEORIA, Ill., May 9, 2016 -- Caterpillar Inc. (NYSE: CAT) Group Preside...
Caterpillar Financial Announces Results as of Early Participation Date and Determination of Pricing Terms of Exchange Offers NASHVILLE, Tenn., Sept. 22, 2016 -- Caterpillar Financial Services Corp...
Companies to optimize manufacturing process using GE FlexFactory CHALFONT ST. GILES, UK and KINGSTON, ONTARIO, CANADA – 8 June 2016 – PnuVax Incorporated (PnuVax), a vaccine and biopha...
Joint Development of Future Generation Continuous Glucose Monitoring (CGM) Systems Aims to Provide Actionable Insights to Help Deliver Integrated Diabetes Care DUBLIN and SAN DIEGO - May ...
GelTex Pharmaceuticals, Inc. is developing non-absorbed, polymer-based pharmaceuticals that selectively bind to andeliminate target substances from the intestinal tract. In October 1998, the Company r...
We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s ...
We have published hundreds of GelTex Incorporated news stories on BioPortfolio along with dozens of GelTex Incorporated Clinical Trials and PubMed Articles about GelTex Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GelTex Incorporated Companies in our database. You can also find out about relevant GelTex Incorporated Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...